AI visibility for Biotech
Buyers ask AI which platform and partner to trust. Here is how Biotech teams can enter enterprise without tripping over regulatory claims are strict.
Buyers ask AI which platform and partner to trust. The opportunity for Biotech teams is not a bigger content budget; it is being the answer to the ten questions that decide a shortlist. This is the plan to enter enterprise without ignoring the constraint that makes Biotech different.
For Biotech, enter enterprise starts with the buyer questions that name your category, your constraint and your price. Win ten of those in 6 engines before expanding. Every claim needs a source, a date and an owner, because regulatory claims are strict.
- Buyer prompts
- 10–20 to start
- Time to signal
- 30–60 days
- Must-have
- author + date + source
- Plan
- from $49/mo
What Biotech buyers ask AI
| Question shape | Why it matters | Page that should win |
|---|---|---|
| best Biotech platform for [size] | Shortlist creation | Comparison page |
| how does [product] handle Biotech | Fit and constraint | Use-case page |
| is [vendor] compliant with regulatory | Risk check | Trust / security page |
| what does [category] cost for Biotech | Budget approval | Pricing / cost guide |
| Biotech case study for [outcome] | Proof | Case study |
The compliance line
Regulatory claims are strict. AI answers are not exempt from that. Every page you want cited should say what the product does, what it does not do, who it is for and where the evidence lives. A confident answer that overstates is a liability, not a win.
The 90-day plan
- 1Week 1: map the buying questions
Interview three buyers or three salespeople. Capture the exact wording, not your paraphrase.
- 2Week 2: baseline
Run the questions in 6 engines. Note who is cited and what claim they make.
- 3Weeks 3–4: build the ten pages
One page per question shape. Name the constraint, show the proof, state the price.
- 4Weeks 5–8: publish and re-check
Two pages a week, re-check after 14 days. Fix crawl access before rewriting.
- 5Weeks 9–12: add proof assets
One case study, one data page, one expert quote. Proof is what turns a citation into a recommendation.
Benchmarks to target
| Metric | 90-day target | Why |
|---|---|---|
| Share of answer | 25–40% | Enough to appear in shortlists |
| Branded accuracy | 100% | Wrong facts cost deals |
| Citation quality | Owned + third-party | Diversity is a trust signal |
| AI referral traffic | Measurable | Early demand signal |
Tooling and budget
| Plan | Monthly | Annual (per month) | Annual total | Brands | Engines | Prompts |
|---|---|---|---|---|---|---|
| Starter Solo marketers and founders | $49/mo | $39/mo | $468 | 1 | 3 | 100 |
| Growth In-house marketing teams | $149/mo | $119/mo | $1,428 | 3 | 6 | 1,000 |
| Scale Multi-brand and agency teams | $399/mo | $319/mo | $3,828 | 10 | 6 | 10,000 |
Frequently asked questions
How do Biotech teams start with AI visibility?
Does compliance limit what we can publish?
Which plan fits Biotech?
Methodology and sources
- Citekit product and pricing data, 9 November 2026.
- Vendor pricing pages and product documentation, checked November 2026. Verify current pricing with each vendor before purchase.
- Public documentation for schema.org, llms.txt and the AI engines named on this page.
How Citekit compares
Citekit is measured against Profound, Scrunch AI, Otterly.AI and nine other tools in the category. The table is the short version; every comparison has a full, sourced page.
| Tool | Entry price | Engines | Best fit |
|---|---|---|---|
| Profound | from $499/mo | 4 | Enterprise teams with a dedicated analyst |
| Scrunch AI | from $250/mo | 5 | Mid-market content teams |
| Otterly.AI | from $29/mo | 4 | Small teams testing AI visibility |
Full comparisons: Profound · Scrunch AI · Otterly.AI · all 12 competitors
Citekit Research. “AI visibility for Biotech: how to enter enterprise in 2026.” Citekit, updated 8 August 2024. https://citekit.apps.antelligen.com/industries/ai-visibility-for-biotech-enter-enterprise